Bristol Myers Squibb (NYSE: BMY; BMS) beat analyst consensus forecasts by reporting higher than expected numbers for total revenue and its “growth” portfolio of drugs on which BMS is counting on for ...

A gene expression program executed by neutrophils and a corresponding biomarker support tumor progression across human and murine tumors.

Shweta Maniar, global director, life sciences strategy & solutions for Google Cloud, recently discussed with GEN Edge the survey and the broader challenges faced by life sciences and healthcare users ...

HIEs were used to identify why the growth of norovirus in culture stops and to determine methods to maintain growth.

Preclinical study findings point to new possibilities for strategies for treating metastatic TNBC patients for whom there are no specific therapies.

Broadly neutralizing antibodies, or bnAbs, are a long‑standing goal of HIV vaccine research because they can disable many strains of the virus at once.

Researchers say the deep learning model may help to create leads for new cancer diagnostics, patient stratification, and future therapies.

A new predictive framework reprograms T cells to sustain immune memory while preserving their ability to fight cancer and infections.

Immunotherapy that blocks microglial Fcγ receptors prevents dopaminergic neuron loss in Parkinson’s disease, revealing a potential new strategy.

CEPI will work with Samsung Biologics to establish a scalable, rapid manufacturing process for recombinant-protein vaccines.

The biopharmaceutical sector is transitioning from reactive off-line quality control to a proactive quality by design (QbD) framework. Process analytical technology (PAT) enables this shift through ...

Bracco’s cell selection and activation microbubble technology is designed to support both positive- and negative-selection strategies.